PHARMACEUTICAL COMPOSITION COMPRISING (1R,4R)-6-FLUORO-N,N-DIMETHYL-4-PHENYL-4,9-DIHYDRO-3H-SPIRO[CYCLOHEXANE-1,1-PYRANO [3,4,B]INDOL]-4-AMINE AND A GABAPENTINOID
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient selected from (1r,4r)-6&prime-fluoro-N,N-dimethyl-4-phenyl-4&prime,9&prime-dihydro-3&primeH-spiro[cyclohexane-1,1&prime-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient selected from gabapentinoids and the physiologically acceptable salts thereof.